STRO - Sutro Biopharma GAAP EPS of -$1.78 beats by $1.31 revenue of $153.73M beats by $101.4M March, 26 2024 02:02 AM Sutro Biopharma Inc. 2024-03-26 02:02:34 ET More on Sutro Biopharma Sutro: Luveltamab Data At ESMO Signifies Continued ADC Advancement Seeking Alpha’s Quant Rating on Sutro Biopharma Historical earnings data for Sutro Biopharma Financial information for Sutro Biopharma For further details see: Sutro Biopharma GAAP EPS of -$1.78 beats by $1.31, revenue of $153.73M beats by $101.4M